Aulitzky WE - Search Results

1

Induction of accessory cell function of human alveolar macrophages by inhalation of human natural interleukin-2.

Zissel G, Aulitzky WE, Lorenz J, Huber C, Müller-Quernheim J. Zissel G, et al. Among authors: aulitzky we. Cancer Immunol Immunother. 1996 Feb;42(2):122-6. doi: 10.1007/s002620050261. Cancer Immunol Immunother. 1996. PMID: 8620521 Free PMC article. Clinical Trial.

2

Spontaneous and interleukin-2-modulated cytokine release by bronchoalveolar cells in pulmonary malignancy.

Gaede KI, Zissel G, Schwuléra U, Struff WG, Lorenz J, Aulitzky WE, Zipfel P, Schrum S, Schlaak M, Huber C, Müller-Quernheim J. Gaede KI, et al. Among authors: aulitzky we. Eur Cytokine Netw. 1997 Dec;8(4):395-400. Eur Cytokine Netw. 1997. PMID: 9459620 Free article.

3

Immunomodulatory and hematopoietic effects of recombinant human interleukin-6 in patients with advanced renal cell cancer.

Schuler M, Peschel C, Schneller F, Fichtner J, Färber L, Huber C, Aulitzky WE. Schuler M, et al. Among authors: aulitzky we. J Interferon Cytokine Res. 1996 Nov;16(11):903-10. doi: 10.1089/jir.1996.16.903. J Interferon Cytokine Res. 1996. PMID: 8938565 Clinical Trial.

4

Lack of efficacy of recombinant human interleukin-6 in patients with advanced renal cell cancer: results of a phase II study.

Schuler M, Bruntsch U, Späth-Schwalbe E, Schrezenmeier H, Peschel C, Färber L, Burger KJ, Leissner J, Huber C, Aulitzky WE. Schuler M, et al. Among authors: aulitzky we. Eur J Cancer. 1998 Apr;34(5):754-6. doi: 10.1016/s0959-8049(97)10089-2. Eur J Cancer. 1998. PMID: 9713286 Clinical Trial.

5

Phase I trial of inhaled natural interleukin 2 for treatment of pulmonary malignancy: toxicity, pharmacokinetics, and biological effects.

Lorenz J, Wilhelm K, Kessler M, Peschel C, Schwulera U, Lissner R, Struff WG, Huland E, Huber C, Aulitzky WE. Lorenz J, et al. Among authors: aulitzky we. Clin Cancer Res. 1996 Jul;2(7):1115-22. Clin Cancer Res. 1996. PMID: 9816276 Clinical Trial.

6

Inhibition of interleukin-11 by interferon-alpha in human bone marrow stromal cells.

Aman MJ, Bug G, Aulitzky WE, Huber C, Peschel C. Aman MJ, et al. Among authors: aulitzky we. Exp Hematol. 1996 Jul;24(8):863-7. Exp Hematol. 1996. PMID: 8690043

7

Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancer.

Portielje JE, Kruit WH, Schuler M, Beck J, Lamers CH, Stoter G, Huber C, de Boer-Dennert M, Rakhit A, Bolhuis RL, Aulitzky WE. Portielje JE, et al. Among authors: aulitzky we. Clin Cancer Res. 1999 Dec;5(12):3983-9. Clin Cancer Res. 1999. PMID: 10632329 Clinical Trial.

8

Clinical applications of cytokines.

Peschel C, Huber C, Aulitzky WE. Peschel C, et al. Among authors: aulitzky we. Presse Med. 1994 Jun 18;23(23):1083-91. Presse Med. 1994. PMID: 7971820 Review.

9

Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes.

Aman MJ, Tretter T, Eisenbeis I, Bug G, Decker T, Aulitzky WE, Tilg H, Huber C, Peschel C. Aman MJ, et al. Among authors: aulitzky we. Blood. 1996 Jun 1;87(11):4731-6. Blood. 1996. PMID: 8639843 Free article.

10

Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-gamma).

Aulitzky WE, Grosse-Wilde H, Westhoff U, Tilg H, Aulitzky W, Gastl G, Herold M, Huber C. Aulitzky WE, et al. Among authors: aulitzky w. Clin Exp Immunol. 1991 Nov;86(2):236-9. doi: 10.1111/j.1365-2249.1991.tb05802.x. Clin Exp Immunol. 1991. PMID: 1934591 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters